The Cavity Is Not the Disease: Dr. V. Kim Kutsch on Silver Diamine Fluoride and Modern Caries Management
For generations, dentists were trained to recognize dental caries by what it eventually produced, a hole in a tooth. Find the decay, remove the damaged tissue, restore the tooth, and move on. It was an enormously successful mechanical solution to an infectious and biological problem, but it also encouraged dentistry to confuse the consequence of disease with the disease itself.
Long before silver diamine fluoride became a mainstream topic in American dentistry, Dr. V. Kim Kutsch was asking dentists to reconsider that assumption. His most important contribution to today’s SDF debate is not that he championed a particular material or protocol. It is that he helped articulate a different way of thinking about dental caries.
In a 2011 review with Dr. Douglas Young, Kutsch argued that the familiar story of Streptococcus mutans and Lactobacillus as the principal villains of tooth decay was too simple. Caries was better understood as a multifactorial disease involving a cariogenic biofilm operating in an oral environment where pathological forces had overwhelmed protective ones. In his 2014 review, Dental Caries: An Updated Medical Model of Risk Assessment, Kutsch pushed the clinical implication further. Restoring a carious lesion repairs damaged tooth structure, but it does not necessarily change the biological conditions that produced the lesion.
That idea has aged remarkably well.
Today the American Dental Association describes caries as a biofilm mediated, sugar driven, multifactorial, dynamic disease involving cycles of demineralization and remineralization. The ADA also states that the traditional drill and fill paradigm does not address the full continuum of the disease process. In other words, much of what once sounded like a challenge to conventional restorative dentistry now appears in mainstream descriptions of caries management.
This distinction matters every day in the operatory. A patient presents with three new lesions. The traditional question is straightforward. Which teeth need restorations? The more useful question begins one step earlier. Why did this patient develop three new lesions?
Maybe the patient sips a sweetened beverage throughout the workday. Maybe xerostomia followed a medication change. Maybe plaque control has deteriorated. Perhaps fluoride exposure is inadequate, previous disease activity is high, or several factors are operating simultaneously. The restoration may still be necessary, but if the environment remains unchanged, beautifully placed composite does little to change the probability of the next lesion.
That is the enduring strength of Kutsch’s medical model. It changes treatment planning from a tooth centered event into disease management. Risk assessment, lesion activity, diet, saliva, fluoride exposure, biofilm, previous caries experience, patient behavior, and protective factors become part of the diagnosis rather than an afterthought following restorative treatment.
CAMBRA, Caries Management by Risk Assessment, grew from this broader movement. There is meaningful clinical evidence behind the approach. A two year randomized practice based study involving 460 patients found significantly lower caries risk levels and disease indicators in patients receiving active CAMBRA treatment compared with standard care.
But this is also where dentists should resist turning a useful framework into a crystal ball. A recent systematic review found only moderate predictive accuracy among current caries risk assessment systems. For CAMBRA, pooled sensitivity was about 68 percent and specificity about 59 percent, with substantial variability among studies. Risk assessment can organize clinical thinking and guide management, but it cannot precisely predict an individual patient’s biological future.
That distinction becomes even more important when discussing antimicrobials. Kutsch’s ecological model does not automatically prove that every attempt to chemically alter the biofilm will prevent cavities. Chlorhexidine provides a useful example. It can reduce mutans streptococci, yet systematic reviews have found that reducing bacterial counts does not consistently translate into fewer carious lesions. Biological plausibility and clinical effectiveness are not the same endpoint.
This is where SDF becomes especially interesting. Silver diamine fluoride is no longer merely an unconventional idea advocated by minimally invasive dentists. The ADA’s evidence based guidance includes 38 percent SDF among nonrestorative caries treatments and recommends prioritizing biannual 38 percent SDF for arresting advanced cavitated coronal lesions in primary teeth, with application also considered in selected permanent teeth. The ADA emphasizes patient specific treatment planning, informed consent, and continued monitoring.
That does not make SDF a replacement for restorative dentistry. It makes the old choice between doing nothing and drilling obsolete.
A modern dentist has a broader continuum of care. Some early lesions can be remineralized or monitored. Some can be sealed or infiltrated. Some cavitated lesions can be arrested with SDF. Some teeth require restorations, and others eventually require endodontic treatment, crowns, or extraction. The appropriate decision depends on lesion activity, cavitation, cleansability, tooth location, dentition, caries risk, patient cooperation, esthetic expectations, access to care, cost, and patient preferences.
That last factor deserves more attention than it receives. SDF changes the economics and psychology of treatment. For a young child who cannot tolerate conventional restorative care, an older adult with root caries and limited dexterity, a medically fragile patient, or someone with limited access to treatment, arresting disease without a handpiece may fundamentally change the conversation. The tradeoff is obvious, arrested carious tissue darkens. That means informed consent cannot be an afterthought. The patient or parent needs to understand what SDF can accomplish, what it cannot accomplish, what the tooth may look like afterward, and why follow up remains necessary.
There is also an uncomfortable business question embedded in this discussion. Dentistry has historically been compensated primarily for procedures. A crown, composite, or extraction is easy to see, code, schedule, and value. Disease management is less tangible. Preventing the restoration that never needs to be placed is clinically valuable, but our traditional economic systems have not always rewarded it accordingly.
That does not mean restorative dentists overtreat patients because they are paid to restore teeth, any more than a company selling preventive products should automatically be distrusted. It means incentives exist on every side of dentistry, and good clinicians should recognize them. Kutsch himself has been a clinician, researcher, inventor, educator, and businessman associated with CariFree. That does not invalidate his ideas, but claims involving proprietary therapies deserve the same independent scrutiny we should demand of implant companies, pharmaceutical manufacturers, insurance carriers, DSOs, universities, and our own preferred treatment philosophies.
This is perhaps the most useful way to understand what Kutsch got right. We do not need to accept every antimicrobial protocol, proprietary product, or dramatic treatment claim to recognize that his larger model was pointing dentistry in the right direction.
Modern caries management is not medicine versus surgery. It is medicine plus surgery when surgery is necessary. The dentist manages the disease biologically while repairing irreversible structural damage appropriately. The objective is not to drill every lesion, nor is it to avoid restorative dentistry at all costs. The objective is to understand what is happening, alter modifiable disease drivers when possible, preserve natural tooth structure, and intervene mechanically when the condition of the tooth requires it.
That approach also changes patient communication. Instead of saying, “You have three cavities,” we can explain, “You have active caries disease, and three teeth are showing the damage from it. We need to decide which teeth require repair, but we also need to understand why this is happening so we can reduce the chance that we are having this same conversation two years from now.”
That may ultimately be Kutsch’s most important contribution to the SDF debate. The argument was never really about silver diamine fluoride. SDF simply exposes a much larger question about what dentists believe they are treating.
If filling the cavity does not necessarily treat the disease, what exactly should modern caries treatment look like?
Join the Conversation!